Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 23 |
NetGPI | no | yes: 0, no: 23 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 22 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
GO:0016020 | membrane | 2 | 3 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0031019 | mitochondrial mRNA editing complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0045293 | mRNA editing complex | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IC11
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 24 |
GO:0006396 | RNA processing | 6 | 24 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 24 |
GO:0006807 | nitrogen compound metabolic process | 2 | 24 |
GO:0008152 | metabolic process | 1 | 24 |
GO:0009987 | cellular process | 1 | 24 |
GO:0016070 | RNA metabolic process | 5 | 24 |
GO:0031123 | RNA 3'-end processing | 7 | 24 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 24 |
GO:0043170 | macromolecule metabolic process | 3 | 24 |
GO:0044237 | cellular metabolic process | 2 | 24 |
GO:0044238 | primary metabolic process | 2 | 24 |
GO:0046483 | heterocycle metabolic process | 3 | 24 |
GO:0071076 | RNA 3' uridylation | 8 | 24 |
GO:0071704 | organic substance metabolic process | 2 | 24 |
GO:0090304 | nucleic acid metabolic process | 4 | 24 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 24 |
GO:0006378 | mRNA polyadenylation | 7 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0031124 | mRNA 3'-end processing | 8 | 1 |
GO:0043631 | RNA polyadenylation | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 24 |
GO:0005488 | binding | 1 | 24 |
GO:0016740 | transferase activity | 2 | 24 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 24 |
GO:0016779 | nucleotidyltransferase activity | 4 | 24 |
GO:0043167 | ion binding | 2 | 24 |
GO:0043169 | cation binding | 3 | 24 |
GO:0046872 | metal ion binding | 4 | 24 |
GO:0050265 | RNA uridylyltransferase activity | 4 | 24 |
GO:0070569 | uridylyltransferase activity | 5 | 24 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 24 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 24 |
GO:0004652 | obsolete polynucleotide adenylyltransferase activity | 6 | 4 |
GO:0070566 | adenylyltransferase activity | 5 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.518 |
CLV_NRD_NRD_1 | 193 | 195 | PF00675 | 0.284 |
CLV_NRD_NRD_1 | 495 | 497 | PF00675 | 0.529 |
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.260 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.336 |
CLV_PCSK_KEX2_1 | 495 | 497 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.418 |
CLV_PCSK_PC1ET2_1 | 138 | 140 | PF00082 | 0.244 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.341 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 272 | 276 | PF00082 | 0.344 |
CLV_PCSK_SKI1_1 | 489 | 493 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.379 |
DEG_APCC_DBOX_1 | 155 | 163 | PF00400 | 0.344 |
DEG_APCC_DBOX_1 | 196 | 204 | PF00400 | 0.284 |
DEG_COP1_1 | 273 | 283 | PF00400 | 0.284 |
DEG_SPOP_SBC_1 | 36 | 40 | PF00917 | 0.688 |
DOC_CYCLIN_yCln2_LP_2 | 365 | 371 | PF00134 | 0.366 |
DOC_PP1_RVXF_1 | 353 | 360 | PF00149 | 0.378 |
DOC_PP4_FxxP_1 | 126 | 129 | PF00568 | 0.470 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.461 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.618 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.627 |
DOC_USP7_UBL2_3 | 138 | 142 | PF12436 | 0.455 |
DOC_USP7_UBL2_3 | 322 | 326 | PF12436 | 0.316 |
DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.354 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.673 |
DOC_WW_Pin1_4 | 30 | 35 | PF00397 | 0.718 |
DOC_WW_Pin1_4 | 375 | 380 | PF00397 | 0.372 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.457 |
LIG_14-3-3_CanoR_1 | 15 | 25 | PF00244 | 0.550 |
LIG_14-3-3_CanoR_1 | 182 | 188 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 194 | 203 | PF00244 | 0.229 |
LIG_14-3-3_CanoR_1 | 232 | 236 | PF00244 | 0.288 |
LIG_14-3-3_CanoR_1 | 414 | 420 | PF00244 | 0.310 |
LIG_14-3-3_CanoR_1 | 473 | 479 | PF00244 | 0.450 |
LIG_Actin_WH2_2 | 4 | 20 | PF00022 | 0.616 |
LIG_AP2alpha_2 | 361 | 363 | PF02296 | 0.335 |
LIG_CaMK_CASK_1 | 226 | 232 | PF00069 | 0.300 |
LIG_Clathr_ClatBox_1 | 438 | 442 | PF01394 | 0.252 |
LIG_CtBP_PxDLS_1 | 385 | 389 | PF00389 | 0.316 |
LIG_deltaCOP1_diTrp_1 | 422 | 427 | PF00928 | 0.284 |
LIG_eIF4E_1 | 103 | 109 | PF01652 | 0.528 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.634 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.457 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.358 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.378 |
LIG_FHA_2 | 187 | 193 | PF00498 | 0.424 |
LIG_FHA_2 | 197 | 203 | PF00498 | 0.424 |
LIG_FHA_2 | 242 | 248 | PF00498 | 0.346 |
LIG_LIR_Apic_2 | 422 | 428 | PF02991 | 0.271 |
LIG_LIR_Gen_1 | 141 | 152 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 434 | 441 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 442 | 453 | PF02991 | 0.324 |
LIG_LIR_Gen_1 | 5 | 13 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 141 | 147 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 289 | 295 | PF02991 | 0.259 |
LIG_LIR_Nem_3 | 344 | 350 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 376 | 380 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 434 | 438 | PF02991 | 0.305 |
LIG_LIR_Nem_3 | 442 | 448 | PF02991 | 0.262 |
LIG_LIR_Nem_3 | 5 | 11 | PF02991 | 0.469 |
LIG_NRBOX | 387 | 393 | PF00104 | 0.300 |
LIG_Pex14_1 | 288 | 292 | PF04695 | 0.296 |
LIG_Pex14_2 | 284 | 288 | PF04695 | 0.304 |
LIG_Pex14_2 | 377 | 381 | PF04695 | 0.246 |
LIG_SH2_CRK | 185 | 189 | PF00017 | 0.443 |
LIG_SH2_GRB2like | 174 | 177 | PF00017 | 0.446 |
LIG_SH2_NCK_1 | 445 | 449 | PF00017 | 0.300 |
LIG_SH2_PTP2 | 10 | 13 | PF00017 | 0.480 |
LIG_SH2_SRC | 445 | 448 | PF00017 | 0.300 |
LIG_SH2_SRC | 481 | 484 | PF00017 | 0.521 |
LIG_SH2_SRC | 8 | 11 | PF00017 | 0.471 |
LIG_SH2_STAP1 | 270 | 274 | PF00017 | 0.284 |
LIG_SH2_STAP1 | 341 | 345 | PF00017 | 0.297 |
LIG_SH2_STAP1 | 399 | 403 | PF00017 | 0.255 |
LIG_SH2_STAP1 | 405 | 409 | PF00017 | 0.230 |
LIG_SH2_STAP1 | 47 | 51 | PF00017 | 0.496 |
LIG_SH2_STAT3 | 150 | 153 | PF00017 | 0.253 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.390 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.275 |
LIG_SH2_STAT5 | 270 | 273 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 279 | 282 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 301 | 304 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 306 | 309 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 350 | 353 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 437 | 440 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 481 | 484 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.495 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.733 |
LIG_SH3_3 | 366 | 372 | PF00018 | 0.337 |
LIG_SUMO_SIM_par_1 | 158 | 164 | PF11976 | 0.289 |
LIG_SUMO_SIM_par_1 | 408 | 413 | PF11976 | 0.319 |
LIG_TRAF2_1 | 189 | 192 | PF00917 | 0.284 |
MOD_CDK_SPxxK_3 | 164 | 171 | PF00069 | 0.347 |
MOD_CDK_SPxxK_3 | 94 | 101 | PF00069 | 0.284 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.284 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.422 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.640 |
MOD_CK1_1 | 39 | 45 | PF00069 | 0.607 |
MOD_CK1_1 | 418 | 424 | PF00069 | 0.298 |
MOD_CK1_1 | 46 | 52 | PF00069 | 0.602 |
MOD_CK2_1 | 186 | 192 | PF00069 | 0.284 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.305 |
MOD_CK2_1 | 37 | 43 | PF00069 | 0.716 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.667 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.640 |
MOD_GlcNHglycan | 327 | 330 | PF01048 | 0.356 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.530 |
MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.753 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.378 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.669 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.330 |
MOD_GSK3_1 | 427 | 434 | PF00069 | 0.366 |
MOD_NEK2_1 | 17 | 22 | PF00069 | 0.660 |
MOD_NEK2_1 | 337 | 342 | PF00069 | 0.335 |
MOD_NEK2_1 | 351 | 356 | PF00069 | 0.340 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.344 |
MOD_NEK2_2 | 415 | 420 | PF00069 | 0.435 |
MOD_PK_1 | 142 | 148 | PF00069 | 0.487 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.532 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.496 |
MOD_PKA_2 | 193 | 199 | PF00069 | 0.355 |
MOD_PKA_2 | 231 | 237 | PF00069 | 0.288 |
MOD_PKA_2 | 415 | 421 | PF00069 | 0.328 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.488 |
MOD_Plk_1 | 230 | 236 | PF00069 | 0.340 |
MOD_Plk_1 | 288 | 294 | PF00069 | 0.349 |
MOD_Plk_1 | 487 | 493 | PF00069 | 0.352 |
MOD_Plk_2-3 | 115 | 121 | PF00069 | 0.271 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.317 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.533 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.440 |
MOD_Plk_4 | 297 | 303 | PF00069 | 0.253 |
MOD_Plk_4 | 341 | 347 | PF00069 | 0.308 |
MOD_Plk_4 | 487 | 493 | PF00069 | 0.409 |
MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.349 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.676 |
MOD_ProDKin_1 | 30 | 36 | PF00069 | 0.719 |
MOD_ProDKin_1 | 375 | 381 | PF00069 | 0.380 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.302 |
MOD_SUMO_for_1 | 467 | 470 | PF00179 | 0.365 |
MOD_SUMO_rev_2 | 190 | 196 | PF00179 | 0.288 |
MOD_SUMO_rev_2 | 94 | 102 | PF00179 | 0.284 |
TRG_DiLeu_BaEn_1 | 387 | 392 | PF01217 | 0.354 |
TRG_ENDOCYTIC_2 | 185 | 188 | PF00928 | 0.414 |
TRG_ENDOCYTIC_2 | 445 | 448 | PF00928 | 0.289 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.510 |
TRG_ER_diArg_1 | 182 | 185 | PF00400 | 0.371 |
TRG_ER_diArg_1 | 203 | 206 | PF00400 | 0.391 |
TRG_ER_diArg_1 | 414 | 417 | PF00400 | 0.300 |
TRG_ER_diArg_1 | 494 | 496 | PF00400 | 0.483 |
TRG_Pf-PMV_PEXEL_1 | 63 | 67 | PF00026 | 0.514 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P857 | Leptomonas seymouri | 25% | 97% |
A0A0N1IJQ4 | Leptomonas seymouri | 76% | 100% |
A0A0S4JJR1 | Bodo saltans | 70% | 100% |
A0A0S4JJT6 | Bodo saltans | 27% | 87% |
A0A1X0NSS0 | Trypanosomatidae | 76% | 100% |
A0A1X0NZU6 | Trypanosomatidae | 29% | 97% |
A0A3Q8IHZ8 | Leishmania donovani | 26% | 100% |
A0A3R7K3P5 | Trypanosoma rangeli | 29% | 97% |
A0A3R7KH85 | Trypanosoma rangeli | 26% | 71% |
A0A422NVH7 | Trypanosoma rangeli | 74% | 100% |
A4HEP5 | Leishmania braziliensis | 88% | 100% |
A4HGC0 | Leishmania braziliensis | 25% | 100% |
A4I1X5 | Leishmania infantum | 100% | 100% |
A4I3F3 | Leishmania infantum | 26% | 100% |
C9ZS45 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 75% | 100% |
D0A7Y7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 97% |
E9AY21 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
E9AZP1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
Q4Q8J1 | Leishmania major | 26% | 100% |
Q4Q9F2 | Leishmania major | 97% | 100% |
Q86MV5 | Trypanosoma brucei brucei | 73% | 100% |
V5BG78 | Trypanosoma cruzi | 29% | 97% |
V5BQ07 | Trypanosoma cruzi | 74% | 100% |